PTGS2 and glioblastoma: Given the role of oxidative stress in therapy resistance, our study specifically aimed to determine how COX-2 inhibition could modulate redox homeostasis in GBM cells with different sensitivities to TMZ, ultimately counteracting chemoresistance.